NUVARING
Google image searchProduct monograph
Active ingredients
etonogestrel, 11.4 MG
ethinyl estradiol, 2.6 MG
DIN: 02253186
Dosage form(s): RING (SLOW-RELEASE)
Route(s) of administration: VAGINAL
Schedule: Prescription
Company: ORGANON CANADA INC.
Date: 01-FEB-2022
ATC:
- G02 — OTHER GYNECOLOGICALS (ATC, ATC/DDD, )
- G02B — CONTRACEPTIVES FOR TOPICAL USE (ATC, ATC/DDD)
- G02BB — Intravaginal contraceptives (ATC, ATC/DDD)
- G02BB01 — VAGINAL RING WITH PROGESTOGEN AND ESTROGEN (ATC/DDD)
Reference brand drug: Nuvaring, Haloette
